Restoration Robotics has released the terms of its IPO

By Catherine Sturman
Established in 2002, Restoration Robotics has recently listed the terms for its Initial Public Offering (IPO). The company works to support medical prof...

Established in 2002, Restoration Robotics has recently listed the terms for its Initial Public Offering (IPO). The company works to support medical professionals throughout a patients’ hair restoration surgery, a niche area that is somewhat becoming a lucrative market.

The private company will look to offer over three million shares, with a price range of $7 to $9 within its upcoming flotation. If successful, Restoration Robotics would gain an overall market value of over $220 million, and will be listed on the Nasdaq under the HAIR symbol in October.

National Securities Corporation has been announced as the sole party, with Roth Capital Partners and Craig-Hallum Capital Group acting as co-managers, according to Market Watch.

Related stories

Restoration Robotics’ Artas Robotic Hair Transplant System has become what the company describes as “the first and only physician-assisted system to harvest follicular units directly from the scalp to create recipient implant sites using proprietary algorithms.”

With long-standing expertise in machine vision and robotics, the Artas system can support physicians throughout the complex process, such as the dissection of hair follicles within a two-step procedure, providing support with repetitive processes that demand precision.

Guaranteeing increased patient satisfaction, the system utilises intelligent algorithms and is minimally invasive, providing long-term results.

The company has since raised over $20 million from a private investor.

Share

Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare

Hospitals